Elagolix
CAS 834153-87-6Small Molecule
Overview
Elagolix is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1208155).
Patent & exclusivity (US)
Per the FDA Orange Book (2 approved US products), the latest listed US patent on Elagolix expires 27 Aug 2040. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- 4-[[(1R)-2-[5-(2-fluoro-3-methoxyphenyl)-3-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-4-methyl-2,6-dioxopyrimidin-1-yl]-1-phenylethyl]amino]butanoic acid
- Canonical SMILES
- CC1=C(C(=O)N(C(=O)N1CC2=C(C=CC=C2F)C(F)(F)F)C[C@@H](C3=CC=CC=C3)NCCCC(=O)O)C4=C(C(=CC=C4)OC)F
- InChIKey
- HEAUOKZIVMZVQL-VWLOTQADSA-N
Verified Supplier Partner
Do you supply Elagolix? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.